Bupa and AXA PPP call on the CMA to reconsider its position on HCA

The UK’s two largest PMI providers have called on the Competition and Markets Authority (CMA) to impose price controls and/or smaller divestments on HCA should it decide to abandon the forced sale of a larger site. The CMA is due to make its final decision on the case this month. However, both Bupa and AXA…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?